High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA
暂无分享,去创建一个
M. Aljurf | M. Sanz | T. Owaidah | N. Chaudhri | F. Al Qurashi | F. Al Mohareb | E. Sahovic | F. Al Sharif | H. Al Zahrani | A. Al Shanqeeti | A. Iqbal | S. Zaidi | Z. Nurgat | M. Sanz | N. Chaudhri | A. Shanqeeti | F. Mohareb | Zubeir A. Nurgat | F. Qurashi | F. Sharif | H. A. Zahrani